Barjasteh A, Kaushik N, Choi E, Kaushik N
Int J Mol Sci. 2023; 24(23).
PMID: 38068979
PMC: 10706109.
DOI: 10.3390/ijms242316657.
Laubach M, Herath B, Bock N, Suresh S, Saifzadeh S, Dargaville B
Front Bioeng Biotechnol. 2023; 11:1272348.
PMID: 37860627
PMC: 10584154.
DOI: 10.3389/fbioe.2023.1272348.
Strasenburg W, Jozwicki J, Durslewicz J, Kuffel B, Kulczyk M, Kowalewski A
Front Oncol. 2022; 12:909767.
PMID: 35814405
PMC: 9259835.
DOI: 10.3389/fonc.2022.909767.
Goonoo N, Bhaw-Luximon A
RSC Adv. 2022; 9(32):18124-18146.
PMID: 35702423
PMC: 9115879.
DOI: 10.1039/c9ra02765c.
Aizawa H, Uematsu T, Sato A, Masuki H, Kawabata H, Tsujino T
Int J Implant Dent. 2022; 8(1):21.
PMID: 35491414
PMC: 9058046.
DOI: 10.1186/s40729-022-00419-1.
Melatonin Attenuates RANKL-Induced Osteoclastogenesis via Inhibition of Atp6v0d2 and DC-STAMP through MAPK and NFATc1 Signaling Pathways.
Kim S, Jeong S, Park B, Kim I
Molecules. 2022; 27(2).
PMID: 35056817
PMC: 8781594.
DOI: 10.3390/molecules27020501.
Regulatory role of microRNA-185 in the recovery process after ankle fracture.
Sun D, Liu J, Shi Q, Mu H, Zhou D
Exp Ther Med. 2018; 16(4):3261-3267.
PMID: 30233673
PMC: 6143847.
DOI: 10.3892/etm.2018.6534.
Three-Dimensional In Vitro Hydro- and Cryogel-Based Cell-Culture Models for the Study of Breast-Cancer Metastasis to Bone.
Bray L, Secker C, Murekatete B, Sievers J, Binner M, Welzel P
Cancers (Basel). 2018; 10(9).
PMID: 30150545
PMC: 6162532.
DOI: 10.3390/cancers10090292.
Platelet Rich Plasma: New Insights for Cutaneous Wound Healing Management.
Chicharro-Alcantara D, Rubio-Zaragoza M, Damia-Gimenez E, Carrillo-Poveda J, Cuervo-Serrato B, Pelaez-Gorrea P
J Funct Biomater. 2018; 9(1).
PMID: 29346333
PMC: 5872096.
DOI: 10.3390/jfb9010010.
MicroRNA-185 regulates spinal cord injuries induced by thoracolumbar spine compression fractures by targeting transforming growth factor-β1.
Zhao P, Wang S, Zhou Y, Zheng H, Zhao G
Exp Ther Med. 2017; 13(3):1127-1132.
PMID: 28450952
PMC: 5403375.
DOI: 10.3892/etm.2017.4052.
Osteoblast Differentiation and Bone Matrix Formation In Vivo and In Vitro.
Blair H, Larrouture Q, Li Y, Lin H, Beer-Stoltz D, Liu L
Tissue Eng Part B Rev. 2016; 23(3):268-280.
PMID: 27846781
PMC: 5467150.
DOI: 10.1089/ten.TEB.2016.0454.
Smad4 is required to inhibit osteoclastogenesis and maintain bone mass.
Morita M, Yoshida S, Iwasaki R, Yasui T, Sato Y, Kobayashi T
Sci Rep. 2016; 6:35221.
PMID: 27731422
PMC: 5059689.
DOI: 10.1038/srep35221.
The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases.
Yamaguchi M
Mol Cell Biochem. 2016; 421(1-2):193-203.
PMID: 27573001
DOI: 10.1007/s11010-016-2803-1.
Multifaceted signaling regulators of chondrogenesis: Implications in cartilage regeneration and tissue engineering.
Green J, Tollemar V, Dougherty M, Yan Z, Yin L, Ye J
Genes Dis. 2016; 2(4):307-327.
PMID: 26835506
PMC: 4730920.
DOI: 10.1016/j.gendis.2015.09.003.
FGF2 gene activated matrices promote proliferation of bone marrow stromal cells.
DMello S, Elangovan S, Salem A
Arch Oral Biol. 2015; 60(12):1742-9.
PMID: 26433191
PMC: 4636935.
DOI: 10.1016/j.archoralbio.2015.09.005.
Chemically modified RNA activated matrices enhance bone regeneration.
Elangovan S, Khorsand B, Do A, Hong L, Dewerth A, Kormann M
J Control Release. 2015; 218:22-8.
PMID: 26415855
PMC: 4631704.
DOI: 10.1016/j.jconrel.2015.09.050.
Whole exome sequencing of a single osteosarcoma case--integrative analysis with whole transcriptome RNA-seq data.
Reimann E, Koks S, Ho X, Maasalu K, Martson A
Hum Genomics. 2014; 8:20.
PMID: 25496518
PMC: 4272536.
DOI: 10.1186/s40246-014-0020-0.
IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand.
Guerra-Menendez L, Sadaba M, Puche J, Lavandera J, de Castro L, de Gortazar A
J Transl Med. 2013; 11:271.
PMID: 24161214
PMC: 4231608.
DOI: 10.1186/1479-5876-11-271.
The enhancement of bone regeneration by gene activated matrix encoding for platelet derived growth factor.
Elangovan S, DMello S, Hong L, Ross R, Allamargot C, Dawson D
Biomaterials. 2013; 35(2):737-47.
PMID: 24161167
PMC: 3855224.
DOI: 10.1016/j.biomaterials.2013.10.021.
In vitro and in vivo investigation of the potential of amorphous microporous silica as a protein delivery vehicle.
Chaudhari A, Vanmellaert L, Bauwens M, Vermaelen P, Deroose C, Naert I
Biomed Res Int. 2013; 2013:306418.
PMID: 23991413
PMC: 3749544.
DOI: 10.1155/2013/306418.